Trial intelligence / Profile preview

Olanzapine versus haloperidol for nausea in advanced cancer

ACTRN12619000744156Phase 2Completed

Sponsor
University of Technology Sydney
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of olanzapine and haloperidol, sponsored by University of Technology Sydney. Started Aug 2019; status: completed.

02

Drugs

olanzapinehaloperidol

Beyond the preview

Go deeper on ACTRN12619000744156.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12619000744156.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call